SYNAPSE 3D NODULE ANALYSIS— 510(k) K120679

Name: FDA 510(k) clearance K120679
Creator: U.S. Food and Drug Administration
Published: 2012-06-01

Substantially Equivalent

Fujifilm Medical Systems U.S.A, Inc.

FDA 510(k) clearance K120679 for SYNAPSE 3D NODULE ANALYSIS, Substantially Equivalent on 2012-06-01. Applicant: Fujifilm Medical Systems U.S.A, Inc.. Device class: 2.

Clearance details

Applicant: Fujifilm Medical Systems U.S.A, Inc.
Product code: Code LLZ
Device class: Class 2
Regulation: 21 CFR 892.2050
Advisory panel: Radiology
Date received: 2012-03-06
Decision date: 2012-06-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stamford, CT, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LLZ

view all

More clearances from Fujifilm Medical Systems U.S.A, Inc.

view all

K171291 — FUJIFILM Bronchoscope Model EB-530P2018-01-19
K171207 — FUJIFILM Ultrasonic Processor SP-900 and FUJIFILM Ultrasonic Probe PB2020-M2018-01-11
K173132 — ASPIRE Cristalle2017-10-27
K171463 — ASPIRE Bellus II2017-09-29
K152257 — Fujifilm Duodenoscope Model ED-530XT2017-07-21

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.